Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FSB
1801
DELISTED
Franklin Financial Network, Inc.
FSB
| $3.88M | ﹤0.01% |
150,500
-3,500
| -2% | -$81.9K |
2019 Q2
4 quarters
|
|
1802
Vornado Realty Trust
VNO
$6.04B
| $3.87M | ﹤0.01% |
+101,399
| New | +$3.94M |
2020 Q2
0 quarters
|
|
1803
3D Systems Corp
DDD
$487M
| $3.87M | ﹤0.01% |
553,950
-579,100
| -51% | -$4.33M |
2019 Q3
3 quarters
|
|
1804
Magnachip Semiconductor
MX
$199M
| $3.87M | ﹤0.01% |
375,231
+268,501
| +252% | +$2.99M |
2019 Q2
4 quarters
|
|
1805
SITE Centers
SITC
$158M
| $3.86M | ﹤0.01% |
611,467
-85,108
| -12% | -$417K |
2019 Q1
5 quarters
|
|
1806
Texas Roadhouse
TXRH
$10.9B
| $3.85M | ﹤0.01% |
+73,172
| New | +$3.57M |
2020 Q2
0 quarters
|
|
1807
AMN Healthcare
AMN
$1.46B
| $3.84M | ﹤0.01% |
84,900
+51,500
| +154% | +$2.46M |
2020 Q1
1 quarter
|
|
1808
Atkore
ATKR
$3.21B
| $3.84M | ﹤0.01% |
140,300
-41,700
| -23% | -$1.03M |
2018 Q1
9 quarters
|
|
1809
Southern First Bancshares
SFST
$561M
| $3.83M | ﹤0.01% |
138,307
-16,000
| -10% | -$434K |
2016 Q2
16 quarters
|
|
|
KRA
1810
DELISTED
Kraton Corporation
KRA
| $3.83M | ﹤0.01% |
221,689
-81,280
| -27% | -$1.1M |
2015 Q2
20 quarters
|
|
1811
Invesco Preferred ETF
PGX
$3.6B
| $3.82M | ﹤0.01% |
+270,300
| New | +$3.79M |
2020 Q2
0 quarters
|
|
1812
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.25B
| $3.81M | ﹤0.01% |
+62,900
| New | +$3.45M |
2020 Q2
0 quarters
|
|
1813
Digi International
DGII
$2.71B
| $3.8M | ﹤0.01% |
326,384
-205,716
| -39% | -$2.2M |
2014 Q4
22 quarters
|
|
|
ORTX
1814
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $3.78M | ﹤0.01% |
63,040
+37,320
| +145% | +$3.42M |
2019 Q4
2 quarters
|
|
1815
Interface
TILE
$2.03B
| $3.78M | ﹤0.01% |
464,406
+180,400
| +64% | +$1.53M |
2017 Q4
10 quarters
|
|
1816
Cathay General Bancorp
CATY
$3.94B
| $3.78M | ﹤0.01% |
143,671
-7,000
| -5% | -$179K |
2020 Q1
1 quarter
|
|
1817
Citizens & Northern Corp
CZNC
$451M
| $3.78M | ﹤0.01% |
182,900
-22,500
| -11% | -$425K |
2014 Q4
22 quarters
|
|
1818
iQIYI
IQ
$918M
| $3.76M | ﹤0.01% |
162,000
-111,300
| -41% | -$2.06M |
2020 Q1
1 quarter
|
|
1819
Lexicon Pharmaceuticals
LXRX
$712M
| $3.75M | ﹤0.01% |
1,880,203
+213,605
| +13% | +$419K |
2017 Q1
13 quarters
|
|
|
BLPH
1820
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $3.74M | ﹤0.01% |
298,111
+148,930
| +100% | +$2.08M |
2016 Q2
16 quarters
|
|
1821
Turtle Beach Corp
TBCH
$258M
| $3.74M | ﹤0.01% |
+253,900
| New | +$2.62M |
2020 Q2
0 quarters
|
|
1822
Omega Flex
OFLX
$261M
| $3.73M | ﹤0.01% |
35,300
-1,200
| -3% | -$114K |
2016 Q3
15 quarters
|
|
1823
KVH Industries
KVHI
$110M
| $3.72M | ﹤0.01% |
416,200
-21,100
| -5% | -$186K |
2013 Q2
28 quarters
|
|
1824
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.48B
| $3.69M | ﹤0.01% |
73,900
-24,000
| -25% | -$1.19M |
2018 Q1
9 quarters
|
|
1825
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.37B
| $3.68M | ﹤0.01% |
+146,100
| New | +$3.6M |
2020 Q2
0 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 583 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.